These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 33163558)
1. Myoclonus and COVID-19: A Challenge for the Present, a Lesson for the Future. Latorre A; Rothwell JC Mov Disord Clin Pract; 2020 Nov; 7(8):888-890. PubMed ID: 33163558 [No Abstract] [Full Text] [Related]
2. The serotonin hypothesis of myoclonus from the perspective of neuronal rhythmicity. Welsh JP; Placantonakis DG; Warsetsky SI; Marquez RG; Bernstein L; Aicher SA Adv Neurol; 2002; 89():307-29. PubMed ID: 11968457 [TBL] [Abstract][Full Text] [Related]
3. Myoclonus status revealing COVID 19 infection. Ben Mohamed D; Zouari R; Ketata J; Nabli F; Blel S; Ben Sassi S Seizure; 2023 Jan; 104():12-14. PubMed ID: 36446232 [TBL] [Abstract][Full Text] [Related]
4. Memantine exacerbates myoclonic jerks in a rat model of posthypoxic myoclonus. Tai KK; Truong DD Brain Res; 2010 Jul; 1343():194-8. PubMed ID: 20434435 [TBL] [Abstract][Full Text] [Related]
5. Diaphragmatic myoclonus due to SARS-CoV-2 infection. Borroni B; Gazzina S; Dono F; Mazzoleni V; Liberini P; Carrarini C; Russo M; Pontolillo M; Vecchiet J; Onofrj M; Bonanni L Neurol Sci; 2020 Dec; 41(12):3471-3474. PubMed ID: 33090303 [TBL] [Abstract][Full Text] [Related]
6. Isolated generalized myoclonus immune-mediated by SARS-CoV-2: an illustrative videotaped case. El Otmani H; Moutaouakil F; Ouazzani M; Mjahed K Neurol Sci; 2021 Aug; 42(8):3411-3413. PubMed ID: 33718991 [TBL] [Abstract][Full Text] [Related]
7. Two COVID-19-related video-accompanied cases of severe ataxia-myoclonus syndrome. Przytuła F; Błądek S; Sławek J Neurol Neurochir Pol; 2021; 55(3):310-313. PubMed ID: 34096013 [TBL] [Abstract][Full Text] [Related]
8. Animal model of posthypoxic myoclonus: effects of serotonergic antagonists. Pappert EJ; Goetz CG; Vu TQ; Ling ZD; Leurgans S; Raman R; Carvey PM Neurology; 1999 Jan; 52(1):16-21. PubMed ID: 9921842 [TBL] [Abstract][Full Text] [Related]
9. Animal model of posthypoxic myoclonus: II. Neurochemical, pathologic, and pharmacologic characterization. Kanthasamy AG; Nguyen BQ; Truong DD Mov Disord; 2000; 15 Suppl 1():31-8. PubMed ID: 10755270 [TBL] [Abstract][Full Text] [Related]
10. Relief of intractable posthypoxic myoclonus after administration of agomelatine. González de la Aleja J; Saiz-Díaz RA; De la Peña P Clin Neuropharmacol; 2012; 35(5):258-9. PubMed ID: 22986800 [TBL] [Abstract][Full Text] [Related]
11. Trimethoprim-sulfamethoxazole exacerbates posthypoxic action myoclonus in a patient with suspicion of Pneumocystis jiroveci infection. Jundt F; Lempert T; Dörken B; Pezzutto A Infection; 2004 Jun; 32(3):176-8. PubMed ID: 15188079 [TBL] [Abstract][Full Text] [Related]